Press Enter to search · Esc to close
A new perspective in Aging Cell argues that the body's capacity to buffer immune decline — not the disease markers we obsess over — may be the truer measure of how well we age.
Two new reviews argue your gut bugs are one of the most workable levers on healthy aging — and the plants on your plate are how you nudge them.
A small Duke pilot is reuniting people from a 15-year-old exercise trial to ask a question longevity culture keeps dodging: does the same workout still work as we age?
A new French trial is testing whether decades of exercise preserve a unified signature of biological youth — and population data on diabetes mortality suggests the stakes are higher than we thought.
Transcriptomic clocks are joining PhenoAge and GrimAge in a fast-maturing toolkit — and early longitudinal work hints that ordinary medications may nudge the dial.
A global expert consensus on exercise for healthy aging arrives alongside trials testing very different anti-frailty levers — from blueberries and protein to a growth-hormone-releasing peptide. Together they reframe frailty as something we can actively push back on.
Aging research is consolidating. A new wave of papers reframes the field around drug-targetable biology — and it could change what 'anti-aging' actually means.
A careful re-analysis of the Women's Health Initiative finds metformin initiators outlived sulfonylurea initiators on the way to age 90. It sharpens the longevity debate without ending it.
A new theoretical model suggests only certain longevity interventions actually shrink the years we spend sick — and the shape of a survival curve might tell us which ones.
A landmark UK Biobank analysis maps the proteins that track how fast we're really aging. The science is promising, the consumer tests are not quite ready.